Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
CEO: Vasant Narasimhan. Company website
Novartis AG (NVS) trades at $140.37, down 0.39% on the day, as of Sep 20, 2026 13:06 UTC.
Novartis AG has a market capitalisation of $266.80B, calculated from the live NVS share price and shares outstanding.
NVS trades at a trailing P/E of 21.17, from earnings per share of $6.63 over the last twelve months.
Novartis AG generated revenue of $55.63B over the trailing twelve months, which puts the stock at 4.80 times sales.
Yes. Novartis AG pays a dividend yielding 2.70% on the current share price.
NVS has traded between $121.68 and $170.46 over the past 52 weeks, and the last price is 17.7% below that high.
Yes. Novartis AG keeps 23.09% of revenue as net income over the trailing twelve months.
Wall Street analysts rate NVS Hold, with an average price target of $153.00, 9.0% above the current price.
Novartis AG is classified under the Healthcare sector and the Drug Manufacturers - General industry, and is domiciled in CH.
Vasant Narasimhan is the chief executive of Novartis AG, which employs 75,267 people.
QFI Terminal shows NVS with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open NVS in Terminal See plans